Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming

Jia Liu(Sun Yat-sen University), Huai‐Qiang Ju(Sun Yat-sen University), Zixian Wang(Sun Yat-sen University), Chau‐Wei Wong(Sun Yat-sen University), Aifu Lin(Zhejiang International Studies University), Ying Jin(Harbin Medical University), Mu‐Sheng Zeng(Sun Yat-sen University), Dan Xie(The Eighth Hospital of Xi'an), Heng‐Ying Pu(Sun Yat-sen University), Lin Feng(Peking University), Bo Li(Southwest Medical University), Yun Wang(Shenyang Medical College), Chao Ren(Sun Yat-sen University), Peng Huang(Wildlife Conservation Society), Dongxin Lin(Sun Yat-sen University), Lei Miao(Drug Discovery Laboratory (Norway)), Qi-Nian Wu(Sun Yat-sen University), Rui‐Hua Xu(Sun Yat-sen University), Dong-liang Chen(Sun Yat-sen University), Ming-Ming He(Sun Yat-sen University), De‐Shen Wang(Sun Yat-sen University), Yun-Xin Lu(Sun Yat-sen University), Zexian Liu(Sun Yat-sen University)
Nature Communications
March 20, 2020
10.1038/s41467-020-15112-3
Cited by 258

Related Papers

Circular RNA: metabolism, functions and interactions with proteins
|Molecular Cancer|2020|1.6k
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
|Molecular Cancer|2019|868
N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis
|Nature Communications|2019|836
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet|2023|701
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657